Muscular Dystrophy Association (MDA): Translational Research (LOI)

Drug development program, which is exclusively focused on funding the discovery and clinical application of treatments and cures for neuromuscular diseases. MVP funds projects from proof-of-principle studies through phase 2 trials. Funding ranges for Research and Development (up to $500,000), Preclinical (up to $1 million)' Early Clinical (Phase I/II) (up to $3 million) for 2 years.

https://www.mda.org/research/funding-opportunities